Effect of Photodynamic Therapy as an Adjunct to Non-Surgical Treatment of Periodontitis
PerioFPS
2 other identifiers
interventional
20
1 country
2
Brief Summary
Photodynamic therapy (PDT) is an innovative technique that utilizes light-activated agents, known as photosensitizers, to produce reactive oxygen species capable of targeting and eliminating pathogens. This therapeutic approach has been explored in a variety of medical fields due to its versatility and minimal invasiveness. In the context of periodontal diseases, PDT has emerged as a promising adjunctive treatment in the non-surgical management of periodontitis. Periodontitis, a chronic inflammatory disease caused by the accumulation of pathogenic bacteria in the subgingival environment, is often treated with mechanical debridement, including scaling and root planing (SRP). However, these conventional methods may not always achieve complete bacterial eradication. PDT, when used in conjunction with SRP, has the potential to significantly enhance bacterial elimination. The use of photosensitizers, activated by specific wavelengths of light, leads to the generation of singlet oxygen, which can effectively kill a broad spectrum of periodontal pathogens, including those resistant to antibiotics. As an adjunctive therapy, PDT can improve the clinical outcomes of non-surgical periodontitis treatment by reducing bacterial load, promoting tissue healing, and potentially decreasing the need for more invasive procedures. The ability of PDT to target bacteria without harming surrounding tissues makes it an attractive option for patients who require a non-invasive treatment approach. In conclusion, photodynamic therapy is a valuable addition to periodontal treatment regimens, offering enhanced bacterial reduction and improved therapeutic outcomes in the management of periodontitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2025
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 24, 2025
CompletedStudy Start
First participant enrolled
April 8, 2025
CompletedFirst Posted
Study publicly available on registry
July 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2025
CompletedJuly 17, 2025
July 1, 2025
6 months
January 24, 2025
July 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Microbiology outcome
Changes in the microbiome collected from periodontal pockets sequencing 16S ribosomal RNA gene
From enrollment to the end of treatment at 3 months.
Secondary Outcomes (1)
Clinical outcome
From enrollment to the end of treatment at 3 months.
Study Arms (2)
Non-surgical periodontal treatment
ACTIVE COMPARATORConventional non-surgical treatment - scaling and root planing
Antimicrobial photodynamic therapy
EXPERIMENTALScaling and root planing + aPDT (antimicrobial photodynamic therapy)
Interventions
Removal of deposits above and below the gum line using hand or ultrasonic tools and thorough smoothing of root surfaces to discourage re-accumulation of bacteria.
Non-invasive treatment that uses a combination of a light-sensitive compound (photosensitizer), specific light, and oxygen to generate reactive oxygen species (ROS) that kill bacteria.
Eligibility Criteria
You may qualify if:
- Patients aged 18 years or older with periodontitis diagnosed according to EFP/APA 2018 criteria and with at least 10 teeth in the mouth.
You may not qualify if:
- Periodontal treatment in the previous six months; use of antibiotics, NSAIDs or immunosuppressants in the previous six months; acute oral infection; pregnant or breastfeeding women; teeth with grade III mobility; pockets with PD \> 10 mm; use of antimicrobial mouthwash in the previous two months; patients with diabetes mellitus.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Egas Moniz School of Health and Science
Almada, Monte Da Caparica, 2825-084, Portugal
Egas Moniz School of Health and Science
Almada, Monte Da Caparica, 2829-511, Portugal
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ricardo Dr. Alves, phd
Egas Moniz School of Science and Health
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 24, 2025
First Posted
July 17, 2025
Study Start
April 8, 2025
Primary Completion
September 30, 2025
Study Completion
November 30, 2025
Last Updated
July 17, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share